First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19

计划入组 54 人 · 首次发布于 2020 年 4 月 17 日

Monitoring of Inflammatory Conditions

计划入组 664 人 · 首次发布于 2022 年 7 月 14 日

Palmitoylethanolamide for Chronic Inflammatory Pain Conditions

计划入组 80 人 · 首次发布于 2024 年 2 月 22 日

lung inflammatory disease therapy (COPD)

Bria-Lung

Lung-H1

Lung Therapeutics, Inc.

United States

Sec Lung, LLC

United States

Lung Healing Technologies Inc

United States

RS BioTherapeutics' Novel Compound Shows Promising Anti-Inflammatory Effects in Human Lung Tissue Study

FDA Approves Celltrion's Avtozma, a Tocilizumab Biosimilar, for Multiple Inflammatory Conditions

MoonLake Immunotherapeutics Advances Sonelokimab Through Phase 3 Trials for Multiple Inflammatory Conditions